Holen Sie sich die Stockscreener-App
43.72
4.74%
1.98
Vorhandelsmarkt:
43.95
0.23
+0.53%
Schlusskurs vom Vortag:
$41.74
Offen:
$42.14
24-Stunden-Volumen:
850.24K
Relative Volume:
0.95
Marktkapitalisierung:
$2.94B
Einnahmen:
$2.82B
Nettoeinkommen (Verlust:
$-1.87B
KGV:
-1.567
EPS:
-27.9
Netto-Cashflow:
$-96.80M
1W Leistung:
+6.37%
1M Leistung:
-2.50%
6M Leistung:
+26.03%
1J Leistung:
-38.72%
1-Tages-Spanne:
$42.14
$43.75
1-Wochen-Bereich:
$39.18
$43.75
52-Wochen-Spanne:
$29.73
$73.45
Quidelortho Corporation Stock (QDEL) Company Profile
Firmenname
Quidelortho Corporation
Sektor
Branche
Telefon
(858) 552-1100
Adresse
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Vergleichen Sie QDEL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
43.72 | 2.94B | 2.82B | -1.87B | -96.80M | -27.90 |
|
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-09-19 | Fortgesetzt | UBS | Neutral |
| 2024-09-05 | Hochstufung | Craig Hallum | Hold → Buy |
| 2024-03-04 | Herabstufung | UBS | Neutral → Sell |
| 2024-02-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-14 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-19 | Eingeleitet | Citigroup | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Sell |
| 2022-06-17 | Fortgesetzt | JP Morgan | Neutral |
| 2022-02-22 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-03-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Bestätigt | Barclays | Overweight |
| 2018-01-04 | Hochstufung | CL King | Neutral → Buy |
| 2017-09-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Bestätigt | Canaccord Genuity | Hold |
| 2017-02-17 | Eingeleitet | CL King | Neutral |
| 2016-12-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Bestätigt | Barclays | Overweight |
| 2016-02-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-12-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Eingeleitet | Barclays | Overweight |
| 2013-07-31 | Bestätigt | Canaccord Genuity | Buy |
| 2011-03-03 | Herabstufung | Wedbush | Outperform → Neutral |
Alle ansehen
Quidelortho Corporation Aktie (QDEL) Neueste Nachrichten
QuidelOrtho Stock Down Despite Solid Preliminary Q4 Revenues - MSN
QuidelOrtho (NASDAQ:QDEL shareholders incur further losses as stock declines 6.4% this week, taking three-year losses to 59% - Simply Wall St
QuidelOrtho may be takeover, activist target with CEO exit, share slumpanalyst - MSN
Oak Thistle LLC Acquires New Stake in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho lets go off CEO Douglas Bryant - MSN
QuidelOrtho Breaks Below 200-Day Moving AverageNotable for QDEL - Nasdaq
QuidelOrtho (NASDAQ:QDEL) Stock Price Down 3.2%Here's Why - MarketBeat
Why QuidelOrtho Shares Are Struggling Despite Optimism - TipRanks
Moody National Bank Trust Division Grows Position in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho reports Q4 revenue in line with guidance By Investing.com - Investing.com Australia
QuidelOrtho Corp (QDEL) Trading Down 4.21% on Jan 13 - GuruFocus.com
QuidelOrtho sees Q4 revenue $702M -$707M, consensus $698.04M - TipRanks
QuidelOrtho announces preliminary Q4 2024 revenue in range of $702 million to $707 million - MSN
QuidelOrtho reports Q4 revenue in line with guidance - Investing.com
QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024 - The Bakersfield Californian
Barclays PLC Sells 41,945 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Stocks Showing Improved Relative Strength: QuidelOrtho - Inkl
Quidel completes Ortho deal, emerges as QuidelOrtho - LabPulse
Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm - PR Newswire
JPMorgan Chase & Co. Has $56.25 Million Stock Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Immunoassay Market Strategies, Trends. Forecasts Report 2025: The Drive Towards Newer, More Efficient Diagnostic Instruments - GlobeNewswire Inc.
QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
QuidelOrtho Co. (NASDAQ:QDEL) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
QuidelOrtho Co. (NASDAQ:QDEL) Stock Position Increased by Principal Financial Group Inc. - MarketBeat
QuidelOrtho files to sell 8.26M shares of common stocks by selling shareholders - MSN
QuidelOrtho Co. (NASDAQ:QDEL) Shares Sold by Barclays PLC - MarketBeat
Geode Capital Management LLC Buys 16,059 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Does QuidelOrtho Corporation (QDEL) Have Healthy Long-Term Growth Prospects? - MSN
Insider Buying: QuidelOrtho President Bought US$250k Of Shares - Yahoo Finance
QuidelOrtho's SWOT analysis: stock upgrade amid cost cuts, product launch By Investing.com - Investing.com Australia
State Street Corp Boosts Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho's SWOT analysis: stock upgrade amid cost cuts, product launch - Investing.com
Quantinno Capital Management LP Trims Stock Position in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho Co. (NASDAQ:QDEL) Shares Sold by The Manufacturers Life Insurance Company - MarketBeat
Brian J. Blaser Buys 6,033 Shares of QuidelOrtho Co. (NASDAQ:QDEL) Stock - MarketBeat
QuidelOrtho Announces Appointment of Two Independent Directors to its Board - Milton Daily Standard
Citigroup Upgrades QuidelOrtho (QDEL) - MSN
Citi upgrades Quidel stock to Buy on FY25 growth prospects and margin improvement efforts - Investing.com
QuidelOrtho (NASDAQ:QDEL) Upgraded at Citigroup - MarketBeat
QuidelOrtho expands board with healthcare veterans By Investing.com - Investing.com Canada
QuidelOrtho upgraded to Buy from Neutral at Citi - TipRanks
MetLife Investment Management LLC Sells 25,230 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Jefferies Initiates Coverage of QuidelOrtho (QDEL) with Hold Recommendation - MSN
QuidelOrtho's SWOT analysis: stock outlook amid strategic shifts, market challenges - Investing.com Nigeria
QuidelOrtho (NASDAQ:QDEL) Coverage Initiated at Jefferies Financial Group - MarketBeat
QuidelOrtho expands board with healthcare veterans - Investing.com India
QuidelOrtho Strengthens Board with Experienced Healthcare CEOs - TipRanks
Finanzdaten der Quidelortho Corporation-Aktie (QDEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):